BFM
PLSE icon

Boothbay Fund Management’s Pulse Biosciences PLSE Stock Holding History

Boothbay Fund Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,274
Closed -$28K – 2358
2022
Q3 		$28K Hold
12,274
– – ﹤0.01% 2147
2022
Q2 		$19K Buy
+12,274
New +$30.9K ﹤0.01% 2183

Other funds holding PLSE

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Boothbay Fund Management's PLSE Position: Q4 2022 in Review

Boothbay Fund Management sold out of Pulse Biosciences (PLSE) in Q4 2022, closing a stake of 12,274 shares — an estimated $28K sold.

Boothbay Fund Management first reported a position in PLSE in Q2 2022 and held it in 2 quarters. The position peaked at $28K in Q3 2022. 29 funds tracked by Wall St. Rank hold PLSE as of Q4 2022.

  • Boothbay Fund Management reported no remaining Pulse Biosciences position as of Q4 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 12,274 Pulse Biosciences shares in Q4 2022, an estimated $28K.
  • Boothbay Fund Management first reported a position in Pulse Biosciences in Q2 2022 and held it in 2 quarters.
  • Boothbay Fund Management's Pulse Biosciences position peaked at $28K in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.